OpenURL Connection Search

Select item for more details and to access through your institution.

Prolonged remission state of refractory adult onset Still’s disease following CD34-selected autologous peripheral blood stem cell transplantation.
Published in:
Bone Marrow Transplantation, 2000, v. 25, n. 12, p. 1307, doi. 10.1038/sj.bmt.1702435
By:
- Lanza, F;
- Dominici, M;
- Govoni, M;
- Moretti, S;
- Campioni, D;
- Corte, R La;
- Latorraca, A;
- Tieghi, A;
- Castagnari, B;
- Trotta, F;
- Castoldi, G
Publication type:
Article
Flow cytometry measurement of GM-CSF receptors in acute leukemic blasts, and normal hemopoietic cells.
Published in:
1997
By:
- Lanza, F;
- Castagnari, B;
- Rigolin, G;
- Moretti, S;
- Latorraca, A;
- Ferrari, L;
- Bardi, A;
- Castoldi, G
Publication type:
journal article
FIRST APPLICATION OF MINIMAL RESIDUAL DISEASE ANALYSIS IN SPLENIC MARGINAL ZONE LYMPHOMA TRIALS: PRELIMINARY RESULTS FROM BRISMA/IELSG36 PHASE II STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 224, doi. 10.1002/hon.39_2630
By:
- Ferrero, S.;
- Ladetto, M.;
- Beldjord, K.;
- Drandi, D.;
- Stelitano, C.;
- Bernard, S.;
- Castagnari, B.;
- Bouabdallah, K.;
- Cesaretti, M.;
- Alvarez, I.;
- Gressin, R.;
- Ponzoni, M.;
- Tripodo, C.;
- Traverse‐Glehen, A.;
- Baseggio, L.;
- Liberati, A.;
- Merli, M.;
- Tessoulin, B.;
- Patti, C.;
- Cabras, M.
Publication type:
Article
FIRST APPLICATION OF MINIMAL RESIDUAL DISEASE ANALYSIS IN SPLENIC MARGINAL ZONE LYMPHOMA TRIALS: PRELIMINARY RESULTS FROM BRISMA/IELSG36 PHASE II STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 224, doi. 10.1002/hon.39_2630
By:
- Ferrero, S.;
- Ladetto, M.;
- Beldjord, K.;
- Drandi, D.;
- Stelitano, C.;
- Bernard, S.;
- Castagnari, B.;
- Bouabdallah, K.;
- Cesaretti, M.;
- Alvarez, I.;
- Gressin, R.;
- Ponzoni, M.;
- Tripodo, C.;
- Traverse‐Glehen, A.;
- Baseggio, L.;
- Liberati, A.;
- Merli, M.;
- Tessoulin, B.;
- Patti, C.;
- Cabras, M.
Publication type:
Article

Found: 4

Prolonged remission state of refractory adult onset Still’s disease following CD34-selected autologous peripheral blood stem cell transplantation.

Flow cytometry measurement of GM-CSF receptors in acute leukemic blasts, and normal hemopoietic cells.

FIRST APPLICATION OF MINIMAL RESIDUAL DISEASE ANALYSIS IN SPLENIC MARGINAL ZONE LYMPHOMA TRIALS: PRELIMINARY RESULTS FROM BRISMA/IELSG36 PHASE II STUDY.

FIRST APPLICATION OF MINIMAL RESIDUAL DISEASE ANALYSIS IN SPLENIC MARGINAL ZONE LYMPHOMA TRIALS: PRELIMINARY RESULTS FROM BRISMA/IELSG36 PHASE II STUDY.